Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This dietary supplement is intended for adults over 18 years of age
Check who the prescriber is
Weight loss induced by GLP-1 medications represents an indirect but clinically relevant interaction
UK Evidence and Guidance Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management
Seek immediate medical evaluation if swollen lymph nodes are accompanied by: Systemic symptoms : Unexplained fever, drenching night sweats, or unintentional weight loss (beyond expected tirzepatide-related weight reduction) Rapid enlargement : Lymph nodes that grow quickly over days to weeks Hard, fixed, or irregular nodes : Lymph nodes that feel firm, immobile, or matted together Size : Nodes larger than 1-2 cm (approximately half an inch to one inch) that persist beyond two weeks Location : Supraclavicular (above the collarbone) lymphadenopathy, which has higher association with serious pathology Associated symptoms : Difficulty breathing, swallowing, or persistent cough
There are no data on the presence of tirzepatide in breast milk, and data for use in pregnant patients are insufficient to determine risk
